Su1604 COMPARATIVE EFFECTIVENESS OF GLP-1RAS, SGLT-2 INHIBITORS, AND OTHER GLUCOSE-LOWERING DRUGS ON ADVERSE CARDIOVASCULAR AND MORTALITY OUTCOMES AMONG PATIENTS WITH DIABETES, NAFLD, AND CARDIOVASCULAR DISEASES: A LARGE POPULATIONBASED COHORT STUDY